Murakami Yousuke, Akahoshi Tohru, Kawai Shinichi, Inoue Matsuhisa, Kitasato Hidero
Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Arthritis Rheum. 2002 Sep;46(9):2504-13. doi: 10.1002/art.10468.
To investigate the role of interleukin-10 (IL-10) in the inflammatory response, the antiinflammatory effect of retrovirally transfected IL-10 was evaluated both in vitro and in vivo.
A recombinant retrovirus containing the murine IL-10 gene was constructed using the pLXSN vector and was designated as LXSN-IL-10. Murine IL-10 was introduced into embryonic C57BL/6J fibroblast cells using LXSN-IL-10 to create C57-IL-10 cells. The effect of IL-10 in the culture supernatant of these cells was then evaluated by determining changes in the production of tumor necrosis factor alpha (TNFalpha), macrophage inflammatory protein 1alpha (MIP-1alpha), and MIP-1beta by macrophages. The antiinflammatory effect of C57-IL-10 cells was also investigated using an in vivo model of monosodium urate monohydrate (MSU) crystal-induced acute inflammation.
The IL-10 gene transcript and its product were detected by reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The level of IL-10 in the culture supernatant of C57-IL-10 cells was estimated to be 50 ng/ml. The culture supernatant of these cells exerted the biologic activity of IL-10, showing inhibition of TNFalpha, MIP-1alpha, and MIP-1beta production by macrophages. Injection of C57-IL-10 cells into murine air pouches significantly inhibited MSU crystal-induced cellular infiltration (P < 0.01) and production of the mouse CXC chemokine KC (P < 0.05). These findings were consistent with the results obtained by the injection of recombinant human IL-10 into air pouches.
In this murine air pouch model of MSU crystal-induced inflammation, IL-10 seemed to inhibit the recruitment of neutrophils at least partly by suppressing KC production. These findings seem to suggest that IL-10 gene therapy may be useful for inflammatory diseases.
研究白细胞介素-10(IL-10)在炎症反应中的作用,在体外和体内评估逆转录病毒转染的IL-10的抗炎作用。
使用pLXSN载体构建含小鼠IL-10基因的重组逆转录病毒,命名为LXSN-IL-10。用LXSN-IL-10将小鼠IL-10导入胚胎C57BL/6J成纤维细胞,创建C57-IL-10细胞。然后通过测定巨噬细胞产生肿瘤坏死因子α(TNFα)、巨噬细胞炎性蛋白1α(MIP-1α)和MIP-1β的变化,评估这些细胞培养上清液中IL-10的作用。还使用尿酸单钠(MSU)晶体诱导的急性炎症体内模型研究C57-IL-10细胞的抗炎作用。
分别通过逆转录聚合酶链反应和酶联免疫吸附测定检测到IL-10基因转录本及其产物。C57-IL-10细胞培养上清液中IL-10水平估计为50 ng/ml。这些细胞的培养上清液发挥了IL-10的生物学活性,显示出对巨噬细胞产生TNFα、MIP-1α和MIP-1β的抑制作用。将C57-IL-10细胞注射到小鼠气袋中可显著抑制MSU晶体诱导的细胞浸润(P<0.01)和小鼠CXC趋化因子KC的产生(P<0.05)。这些发现与向气袋中注射重组人IL-10获得的结果一致。
在这个MSU晶体诱导炎症的小鼠气袋模型中,IL-10似乎至少部分通过抑制KC产生来抑制中性粒细胞的募集。这些发现似乎表明IL-10基因治疗可能对炎症性疾病有用。